A revolutionary nanoparticle approach from MIT researchers is overcoming immunotherapy resistance in ovarian cancer. By precisely delivering immune-stimulating molecules directly to tumors, the treatment achieved remarkable 80% cure rates while avoiding the dangerous side effects that have limited s
Cutting-edge research demonstrates how artificial intelligence and nanotechnology are converging to tackle neurodegenerative diseases. Scientists report this interdisciplinary approach could shift treatment paradigms from disease management to disease modification.
Researchers are reportedly developing a groundbreaking approach that combines nanomedicine with artificial intelligence and molecular imaging to tackle neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and ALS. According to a recent review published in Molecular Diagnosis & Therapy, this interdisciplinary strategy could potentially overcome longstanding barriers in treating these complex conditions.
